* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Labeled Phosphate Distribution in Working and Nonworking
Survey
Document related concepts
Heart failure wikipedia , lookup
Electrocardiography wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Mitral insufficiency wikipedia , lookup
Coronary artery disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Jatene procedure wikipedia , lookup
Cardiac surgery wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Cardiothoracic surgery wikipedia , lookup
Myocardial infarction wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Cardiac arrest wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Transcript
Labeled Phosphate Distribution in Working and Nonworking Myocardium Bi/ KENNETH K. TSUBOI, PH.D., NANCY M. BUCKLEY, M.D., AND NORMAN J. ZEIG, M.D. \T isolated dog heart preparation has been . described,1 in which only the left ventricle performs external work. The coronary system is maintained in such hearts with the right ventricle performing no external work. The heinodynamic determinants of the stroke work of the left ventricle can be varied and maintained at desired levels and over fixed intervals. The continuous perfusion of both ventricles by an adequate coronary blood supply and intimate distribution of added metabolites (including isotopically labeled substrates) throughout the myocardium is assured by maintaining the aortic pressure above 70 mm. Hg. The unique experimental advantages of a single heart providing simultaneously both "resting" (i.e., nonworking) and working metabolic states have not been previously duplicated in any biochemical investigation into the work function of this organ. The results of an application of such preparations will be described in the present report in which the comparative metabolism of phosphate compounds in working and nonworking myocardium was examined with the aid of P a2 . Investigation of phosphate compounds was prompted by the recognized obvious importance of certain members of this group and a possible involvement of others in the energy processes associated with the work function of this organ. The intimate partiei- A Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 pation by nucleotides, creatine phosphate and phosphorylated carbohydrates in muscle energetics is well recognized. On the other hand, information concerning the role (if any) of other tissue phosphates including the phospholipids and ribose nucleic acid (RNA) as possible energy substrates is lacking. Investigation of phospholipid metabolism would appear to be especially relevant in view of the demonstrated2'3 ready utilization of fatty acids as an energy source by cardiac tissues. RNA as a possible energy intermediate in muscle metabolism has apparently not been previously considered. An enzyme catalyzed reaction leading to the synthesis of highly polymerized ribonucleotide chains from micleoside diphosphates has been described.4 The reaction is currently viewed as a possible mechanism of cellular RNA synthesis. The reaction has been found to be freely reversible5 and RNA by analogy could therefore conceivably represent a readily available biologic store of high-energy nucleoside polyphosphates. Methods Cardiac Preparation and its Perfusion Left Ventricle Preparations Six dog hearts prepared by procedures detailed in a previous report0 were utilized for the present series of studies. The perfusion circuit of the functionally isolated left ventricle preparations employed is illustrated dingrainmaticnlly in figure 1. The left ventricle (LV) was filled from either of 2 inflow reservoirs: one (P) for perfusion with the isotope-containing medium and the other (W) with isotope-free medium. The hydrostatic pressure available for diastolic filling was kept constant, in either case, at a physiologic level. The contracting left ventricle ejected blood into the coronary circulation and an artificial peripheral circuit which included an arterial resistance unit From the Department of Pediatrics, Cornell University Medical College, and tlie Department of Physiology, Albert Einstein College of Medicine, New York, N. Y. Supported by grants from the PHS (No. H-3477), Commonwealth Fund and the Life Insurance Medical Research Fund (No. G-56-57). Received for publication December 10, 3959. Circulation Research, Volume VIII, July 1980 703 704 TSIJBOT, BUCKLEY, ZEIG Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 Figure 1 Diagrammatic illustration of the external circuit employed with the isolated left ventricle preparation (for details, consult text). (A.R.) of the Starling type and an oxygenator (Ox.) of the Kusserow type. Details concerning the performance of the left ventricle perfused under these conditions have been reported.1 The controllable hemodynamies assured a constant level of left ventricular work and an optimal coronary blood supply. In the present experiments, ventricular performance was evaluated from direct measurements of intraventricular pressure and external work. Left ventricular pressure was registered by a Statham P23D transducer attached to a short 16-gauge cannula in the ventricle and recorded together with an electrocardiogram from the screen of a Tektronix dual-trace oscilloscope. Left ventricular work was calculated as the product of the collected output per minute and mean arterial pressure. The latter was registered on a damped mercury manometer. Right ventricular external work remained at zero. Perfusion Medium Defibrinated whole dog blood or semisynthetie media of low phosphate content were employed, the latter in experiments of short duration where a minimum dilution of added labeled phosphate was desired in order to provide maximum tissue incorporation of the isotope for analytical purposes. The composition of the various media is shown in a footnote to table 1. Isotope Perfusion High specific activity P32-labeled Na 2 HP0 4 was added directly to the circulating medium. Approximately 5 inc. of the isotope and between 200 and 300 ml. perfusion medium were used in all experiments. h Cardi ae ou tput (ml./ min.l Mean aorti pressi re (mm. Hg) Work (Gm. 70 72 60 63 85 60 Perfu mediu 1 2 3 4 5 6 i Heart (Gm. Heart prep. no. Table 1 Work Performance of Cardiac Preparations Employed (A) (B) (B) (A) (A) (G) 300 375 245 330 490 574 70 95 115 75 70 70 286t 484 383 2851 470 570 u *(A) defibrinated whole blood; (B) washed erythrocytes in Kinger's containing 1-2 per cent PVP; (C) washed erythrocytes in Feigen's medium" containing 1-2 per cent PVP. Dextrose (0.1 per cent) and insulin (10 units/100 ml.) were also included in all media. Synthetic salt media contained either 0.25 mg. per cent or no added NanPOi. tDecreased to minimum at time of muscle sampling. 'Wash Procedure for Removal of Excess Isotope Following circulation of the isotope for a desired period of time, excess isotope was washed from the heart by changing to isotope-free medium and continuing the perfusion for an additional 10 minutes. The wash procedure removed excess isotope of extracellular origin, allowing for a reliable measure of the S.A. (specific activity) of the intracellular Pj (inorganic orthophosphate). The level of isotope remaining in the circulatingfluid following isotope perfusion and subsequent wash of a cardiac preparation is shown infigure2. Extraction and Isolation of Phosphorylated Components from Cardiac Muscle Soluble Components On termination of the perfusion procedure, muscle strips from the nonworking right and working left ventricles were rapidly excised, weighed and separately homogenized in 20 volumes of 60 per cent acetone at room temperature. The aqueousacetone extraction was employed for the removal of soluble small molecule phosphates (nucleotides, sugar phosphates, etc.) rather than a conventional perchloric or trichloracetic acid extraction, in order to allow maximum preservation of labile components. Nucleotide extraction with this procedure was only slightly less complete than that obtained with cold perchloric acid. Following removal of acetone in a flash evaporator, the nucleotides were separated free of other Circulation Research, Volume VlIF, July i960 LABELED PHOSPHATE DISTRIBUTION 705 ATP Developm i, GDP Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 \Z/ GTP 10 PERFUSION TIME (MIN.) 20 Figure 2 Isotope perfusion and subsequent removal of excess isotope by further perfusion of a cardiac preparation with isotope-free medium. remaining soluble phosphates on norite A and resolved by 2-diniensional paper chromatography, yielding- products of high radioehemical purity. The result of a typical fnietionation is illustrated in the ra.dioautogrn.ph reproduced in figure 3. Details concerning the isolation technic and identification of individual components have been presented in an earlier report.7 A further fractionation sequence was recently developed8 for the localization of labeled P in nucleoside polyphosphates and has been applied in the present studies for the determination of isotope distribution in cardiac AMP, ADP and ATP. The fractionation is illustrated in the paired radioautographs reproduced in figure 4. Following isolation of AMP, ADP and ATP by an initial development in solvent 1, the ADP and ATP were next partially degraded in situ with acid and heat,8 to yield some AMP from the ADP deposit and both AMP and ADP from the ATP deposit. The resulting mixtures were resolved by a second development (fig. 4 left). A further third development was required (fig. 4 right) to remove derived Pj, which appears as a contaminant of the ADP deposit. The S.A. of each of the individual P groups can now be obtained from measurements on the isolated radio-chemically pure products by procedures which have been detailed in a pi'evious report.7 Radioehemical purity is established for each deposit by in situ technics detailed in a later section. Fractionation of the remaining soluble phosphates, following nueleotide removal on norite A, Circulation Research, Volume VIII, July 1060 ; UOP CD' UDPAG UOPG-*UMP UTP 2nd Developmeni l+Xl Figure 3 liadioautograph of P-1f-labeled dog cardiac nucleotides from heart preparation 5 resolved by 2dimensional paper chromatography. Broken Hues represent compounds located by virtue of radioactivity only; solid lines, those com pounds located in addition by absorption of 25-1-m/j, light. The first development was for 20 hours in solvent 1 and the second for 56 hours in solvent 5. involved a preliminary separation at pH S to 9 of calcium insoluble salts (P, and some fructose diphosphate). Practically all of the remaining phosphates were next isolated as barium salts in the presence of 4 volumes of ethanol and following barium removal, resolved by 2-dimensional paper chromatography. A typical fraetionation is illustrated in the radioautograph reproduced in figure 5. Specific details concerning the isolation and identification of the various components will be published elsewhere. Phospholipids The cardiac residue remaining after initial extraction for soluble phosphates was next extracted 3 times with 10 volumes of acetone and the extracts discarded. The residue was then extracted with 10 volumes of a 2:1 chloroformmethanol mixture. The resulting phospholipid containing extract was concentrated 20-fold, and thoroughly washed by repeated shaking with dilute hydrochloric acid and finally dialyzed. A further isolation of a-glycerophosphate from the phospholipid fraction was accomplished by the following sequence: hydrolysis in 6X hydrochloric acid for 1 hour at 100 C, precipitation of the liberated glycerophosphate as the barium salt with ethanol 706 TSUBOI, BUCKLEY, ZEIU o AMP-: I I mm o •§' S 6-P Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 Tigure 4 Fmrtionation sequence for the localization and measure of labeled P in individual phosphoryl groups of adenine nucleotides. Adenine nucleotides were isolated from an initial complex mixture of dog cardiac nucleotides (preparation 5) by initial development for 20 hours in solvent 1. A DP and ATP deposits were sprayed with dilute HCl (.01 N in 90 per cent EtOH) and heated (16 hours at 80 C). The resulting products were resolved by a second development for 72 hours in solvent, 5 (left). A third development for 18 hours in solvent 3 ivas required to remove contaminating Pi (right). and final isolation in pure form by ehromatography in paper, using solvent 5 (for solvent composition, see later section). UNA Nnclootides Isolation of RNA from the cardiac residue following phospholipid removal was essentially as described in an earlier report.9 The residue was dried and extracted twice with 5 times the original tissue volume of 10 per cent N a d for 30 minute periods at 100 C. To the combined extracts were added 3 volumes of 95 per cent ethanol and the precipitated nucleic acids removed after overnight standing at -20 C. The washed nucleic acids were dissolved and treated with norite A to insure complete removal of possible contaminating free nucleotides,10 then hydrolyzed for 45 minutes at 80 C. in 0.1N NaOH. RNA nucleotides (present as 2' and 3' phosphate mixed isomers) resulting from the alkaline hydrolysis were removed from the digest on norite," following preliminary acidification and removal of insoluble DNA by centrifugation. The norite adsorbed nucleotides were eluted7 and chromatographed on paper in 2 dimensions, using first solvent 1 then 3 (for solvent compositions, see later section) yielding isolated deposits of each in high radiochemical purity (not illustrated). Details concerning the 0 2nd Dtv. O (+X) Figure 5 Radioautograph of PS2-labeled micleotide soluble phosphorylated components from dog heart preparation 4 following resolution by 2-dimensional paper chromatography. First development was for 48 hours in solvent 5j second development for 24 hours in solvent 1. isolation and evaluation of the procedures will be presented in conjunction with other work to be published elsewhere. Isolation, Detection and Measure of Labeled Cardiac Phosphates Resolved by Paper Chromatography Cliromatography Final resolution of the numerous phosphorylated components obtained from the cardiac tissues was achieved in all cases (with the exception of phospholipids) by paper chromatographie technics. The composition of the 3 solvent systems employed in the separations were as follows: solvent 1: 66 vol. isobutyric acid, 33 water, and 1.5 cone. XH 4 0H; 1 1 solvent 3: 60 vol. isopropyl alcohol, 30 glacial acetic acid, and 10 water;12 solvent 5: 60 vol. n-propanol, 30 cone. NH 4 0H, and 10 water.13 Whatman 3MM paper sheets of 18 X 22 inches, washed in 0.1N acetic acid, were employed for the chromatography. Chromatograms were developed by descending technic in stainless steel chromatocabs of appropriate dimension. Detection and Measure Ultraviolet fluoroscopes were prepared" for visualization in chromatograms of purine and pyrimidine containing deposits absorbing 254-m/x light emitted from a Mineralight lamp. Deposits containing labeled phosphate were visualized by radioautography (Kodak, No-Screen x-ray film, 14 X 17 inches). Nonlabeled or weakly labeled (e.g., a-glyeerophosphate from phospholipid), nonCirculation Research, Volume VU1, July I960 LABELED PHOSPHATE DISTEIBUTION Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 nueleotide phosphate deposits were localized by molybdate reduction.14 Quantitative measurements of amount and radioactivity appearing in nueleotide deposits were curried out by procedures designed to provide explicit control of radiochemical purity of the isolated products,7 involving a combination of technics including serial in situ measurements across deposits as well as conventional measurements on the eluted material. The in situ measurements were carried out with an ultraviolet photon counter designed for chromatographic densitometry at 254-m/xlr> and a beta counter for radioactivity, respectively. Measurements of nucleotides in solution, following elution of deposits in 2 per cent NH 4 HC0 3 , were made with a Beckman DU ultraviolet spectrophotometer. Radioactivity was determined on aliquots of the eluted nueleotide solutions. Non-nueleotide phosphates following localization on the chromatogram primarily by radioautography were measured by the following procedures : Each localized deposit was cut out and the paper weighed. Adjacent blank areas of the paper of only approximately equivalent area were also taken and weighed. The cut-out paper areas were transferred to heavy wall pyrex tubes and dry ashed overnight at 400 to 500 C. The resulting minute ashed residues were hydrolyzed in dilute acid and aliquots removed for counting and phosphate determinations.10 Appropriate paper blank corrections (corrected on the basis of amount of molybdate reducing material contributed per unit weight of paper) were essential to obtaining reliable results. Results and Discussion Work Performance of Cardiac Preparations Pertinent physiologic data of each preparation employed in these studies are summarized in table 1. Cardiac output (ml./min.) was calculated as the aortic outflow plus coronary drainage. Mean aortic pressure was calculated as the weighted average of systolic and diastolic pressures. Work per minute (Gm.M/ min.) was calculated as pressure-volume work, the product, of cardiac output and mean aortic pressure. A typical record of left ventricular pressure and electrocardiogram is shown in figure 6. In the 2 hearts in which work per minute decreased by the time of sampling, the left ventricular pressure curve then became characteristic of a hypodynamic ventricle. The work performance of the left ventricle and the analysis of intraveutricular Circulation Research, Volume VIII, July 1900 707 LVP (mm. Hg.) 120-iH *) h-2OO msec. Figure 6 Left ventricular pressure (LVP) and electrocardiograph records from heart #3 (see table 1). pressure curves is comparable to those reported previously for a larger group of dog hearts.1 Iu every heart, right ventricular work was zero. Nucleotides in Working and Nonworking Myocardium Composition Studies Nueleotide components appearing in extracts of dog myocardium have not, apparently, been previously thoroughly resolved. Resolution of dog cardiac nucleotides has been accomplished by 2-dimensional paper chromatography and the results illustrated in the radioautograph reproduced in figure 3. A preliminary examination of uucleotides in working and nonworking myocardium included comparative analyses with respect to composition. The results of a representative set of analyses have been summarized in table 2. In addition to nucleotides, the analyses included all other small-molecule purine and pyrimidine components appearing in the extracts. From the results, it is apparent that only minor differences in composition can be demonstrated with respect to these constituents. Phoxphate-P" Incorporation Studies Further comparative analyses of nucleotides in working and nonworking myocardium included an investigation of the rate of phosphate renewal in adenine nucleotides using P32-labeled phosphate. In these experiments, left ventricles were subjected to various periods of work with the corresponding right ventricles serving as nonworking controls. Details concerning the administration of the isotope have been previously presented. The results of these studies have been summarized in table 3. Differences in labeled phosphate incorporation could not be demonstrated in any TSUBOI, BUCKLEY, ZBIG 708 Table 2 Nucleoticle and Derivatives in Working and Nonworking Dog Myocardium" Compound AMP ADP ATP DPN Inosine Uridine Hypoxantliine Uridine + As fraction of total concentration Non-working (RV) Working (LV) 1.8 2.7 18.6 65.0 20.3 62.1 5.8 1.0 1.1 6.0 1.2 0.9 tnice trace 6.0 6.8 guanosinc polyphosphates Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 •Heart preparation no. 2 (see table 1) was employed for analyses. Components were resolved by 2-dimensioiiiil paper cliromatograpliy, with the exception of the uridine and guanosine polyphosphates. These latter compounds were resolved free of most other niicleotkk's after a single development in solvent 1 and were subsequently measured as a mixture. of the P groups of adenine nueleotides from working as compared with nonworking myocardium following either very short (3 minutes), or long periods (40 minutes) of induced cardiac work. It had been an initial objective of these experiments to attempt a quantitative correlation between cardiac work and highenergy phosphate turnover. It is obvious from the results that a measure of phosphate turnover was not achieved in these experiments. The extent of isotope incorporation in the rapidly exchanged high-energy phosphate groups is unfortunately limited in cardiac muscle (as in striated muscle18) by a prior rate-limiting step involving transfer of the perfused isotope across the cell membrane. Isotope on entry into the cell, by whatever mechanism (see later), presumably equilibrates between the Pi and high-energy phosphate pools by reactions of considerably greater rate. In this respect, isotope equilibration among the high-energy phosphate groups of ADP and ATP occurred within the shortest measured time interval (3 minutes). The apparent lack of equilibration within this period between the high-energy phosphates and tissue Pi was attributed to the contaminating presence of metabolically inactive high- specific activity. Pi of extracellular origin retained in the preparation due to the omission of the wash procedure. In view of the above considerations, investigations relating to nucleotide high-energy phosphate turnover in cardiac tissue using phosphate-P32 as a tracer cannot be considered valid. In this respect, a recent report10 purporting to demonstrate differences in cardiac ATP turnover between young and old rats on the basis of P 32 incorporation rates cannot be accepted. The data in fact appear to support an altered rate of isotope passage into cardiac cells of older rats. Further, a study has been described20 in which an increased rate of phosphate-P82 incorporation into cardiac nucleotide high-energy phosphate groups has been attributed to an increased turnover following induced cardiac work associated with muscular exercise. These conclusions similarly cannot be accepted. In view of the limited samples taken for analyses in these studies (about 30 ing. obtained by biopsy) and the inadequate fractionation technics necessarily employed, the radiochemical purity of the measured products would appear to be questionable. Cardiac Non-nucleotide Soluble Phosphates Composition The remaining non-nucleotide phosphates appearing in aqueous-acetone extracts of dog myocardium have not been previously systematically examined. Fractionation of this group of compounds Avas carried out, by 2dimensional paper chromatography. Resolution of components by these technics is illustrated in the radioautograph reproduced in figure 5. The compound labeled K is a ketohexo.se which has not been further characterized. An unexpected finding was the presence of a-glycerophosphate as a major component in cardiac extracts. Details concerning the isolation and identification of the separated compounds are to be published elsewhere. lJhosphate-P" Incorporation Studies The rate of labeled phosphate incorporation into the non-nucleotide soluble phospliateswas examined as a function of cardiac work. Comparative isotope analyses on isolated compoCirculation Research, Voluvic VIII, July 1960 LABELED PHOSPHATE DLSTKIBUTIOX Labeled 1' Distribution Myocardium Duration of perfusion of isotope* 1. 3 minutes (no wash) AMP ADP ATP 10 minutes (10-minutc wash ) AMP ADP ATP a. 4.0 minutes (10-minutc wash) Table 3 Nucleotides of Working in Adcninr Isolated adenine nucleotide 709 and Nonworking Dog S.A. of P groups relative to p . t Working (LV) P. PPi nucleotide Nonworking (RV) Pl nucleotide Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 <0.01 <0.01 <0.01 0.37 0.37 <0.01 0.98 1.93 <0.01 <0.01 <0.01 0.98 0.95 0.01 0.97 1.98 0.01 0.01 0.01 0.97 0.99 AMP ADP ATP — 0.40 <0.01 0.42 0.79 <0.01 <0.01 <0.01 0.42 0.37 0.98 <0.01 0.97 1.89 <0.01 <0.01 <0.0.1 0.97 0.94 0.92 0.01 0.96 2.01 0.01 0.01 0.01 — <0.01 o.:i7 0.77 __ 0.42 — 0.95 0.98 3.0.1. 0.97 *Cardiae preparations 3, 2 and 1 (see table 1) were employed for the 3-, 10- and 40-niinute isotope perfusion experiments, respectively. tTho summarized results represent averages obtained from at least duplicate determinations and have been computed relative to the S.A. of Pi. P 1 refers to the carbon-bound P, P" to tlie terminal (ADP) or middle P (ATP), and P" to the terminal P of ATP. nents prepared from working left ventricles and nonworking right ventricles failed to reveal differences in labeling rates which could be attributed to the imposed work (for a representative experiment, see table 4). Differences in isotope incorporation which were encountered could be correlated with a corresponding inequality in distribution of the perfused labeled phosphate between the working and nonworking ventricles. Questions relating to the effect of contraction and work on the distribution and transport, of the isofope in muscle tissue will not be considered in this report. Although information relevant to work function was not obtained, the results summarized in table 4 provide evidence for a phosphorylation mechanism (rather than a simple diffusion mechanism) in the transport of externally perfused labeled phosphate across the cell membrane. The results suggested a phosphorylation of hexose as an intermediate reaction (e.g., glycogeu + P ( •* glucose-1-phosphate) in the entry of phosphate into the cell. This conclusion is based on the consistent finding that the hexose phosphate fractions contained isotope in excess of that present in the rapidly exchanged high-energy phosCirculation Research, Volume VIII, July 1960 phate groups of: creatine phosphate, ATP and ADP. If we assume a near constant isotope equilibrium between the intracellular Pi pool and high-energy phosphate groups (for which indirect evidence has been previously presented), Pi cannot possibly represent the entering unit. A direct measure of the isotope content of the intracellular P, pool cannot, unfortunately, be obtained without prior removal of isotope of extracellular origin. The wash procedure has been avoided in these studies in order to preserve the existing isotope distribution pattern among the various measured constituents. Further evidence relating to the postulated transport mechanism has been obtained and will be presented as a separate report. Phospholipid Metabolism in Working and Nonworking Myocardium J'lioxphate-P" Incorporation Studies In the event that phospholipids participate in the recognized ready utilization of fatty acids as an energy source in cardiac muscle,2' 8 it was considered relevant to examine the metabolism of this group of compounds as a function of cardiac work using phosphate-P32 as a tracer. Incorporation of labeled phosphate into phospholipid components in a work- TSUBOI, BUCKLEY, ZEIG 710 Table 4 Labeled P Incorporation in Soluble Organic Phosphates of Working and Nonworking Myocardium" Isolated component! Specific activity (c.p.m./m/imole) Nonworking Working (LV) (RV) a-Glycerophosphate Glucose-1-phosphato 4fructose-6-phosphsite Glucose-6-phosphate Ketohexose phosphate (K) Fructose-l-6-diphosphate Creatiiic phosphate (ADP - P 2 ) (P.)t 77 75 118 110 97 106 83 112 102 95 97 84 (86) (145) (80) (131) Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 'Heart preparation 4 (see table 1) was employed for analyses. Isotope perfusion lasted 25 minutes with no subsequent wash. tlsolation of components was by 2-dimensional paper chroinatography (see fig. 5 for illustration of separated components). tPi fractions are contaminated by isotope of extracellular origin, due to omission of wash procedure in this experiment. ing left and nonworking right ventricle was therefore examined following isotope perfusion of an isolated dog heart preparation. The results of such a study have been summarized in table 5. Labeled phosphate incorporation into cardiac phospholipids differs little in either the working or nonworking myocardium and proceeds at considerably lesser rates than in nucleotide high-energy phosphate groups or glycolytic intermediates. These results suggest either a lack of participation of phospholipids in the energy metabolism of cardiac tissue or the more likely alternative that phosphate turnover is an inadequate measure of an involvement restricted to the nontagged fatty acid residues. Phospholipid cc-Glycerophosphate An additional glycerophosphate containing phospholipid, cardiolipin,21 has been found in cardiac tissue. A further isolation of the glycerophosphate components of the phospholipid fractions was carried out for specific examination. The isotope content of these residues was determined following isolation from acid digests. The glycerophosphate obtained by acid hydrolysis was a mixture of Table 5 Effect of Work on Labeled P Incorporation into Cardiac Phospholipid^ Isolated compound Phospholipid a-G-P (P.) Nonworking (RV) S.A. /imole/ (c.p.m./ Gm. /imole) 15.0 — — 1,300 2,280 300,000 Working (LV) S.A. ymole/ (c.p.m./ Gm. jimole) 14.5 1,000 — 1,420 — 260,000 "Heart preparation o (sec table 1) was employed for analyses. Isotope perfusion was for 40 minutes followed by a 15-minute wash. For details concerning the isolation of components, see "Procedures." both a- and /?-isomers with the former predominating. These results did not differ significantly from those obtained with the intact phospholipid fractions. Isolation of the a-glycerophosphate component was prompted in view of the limited information available on the metabolism of cardiolipin. In addition, it was considered of interest to investigate a possible metabolic relationship between the free a-glycerophosphate described earlier in cardiac extracts with that combined as phospholipid. In view of the finding of considerably less isotope in the lipid bound a-glycerophosphate, it is apparent that this cannot be the source of the soluble, free compound. The relative isotope content of the free a-glycerophosphate is consistent with a metabolic relationship associated with the glycolytic pathway. Metabolism of ENA as a Function of Cardiac Work Phosphate-P" Studies The possibility of RNA participation in the energetics of cardiac tissue was examined using phosphate-P32 incorporation as a measure of relative turnover of individual nucleotide components. RNA as a possible intermediate in nucleotide high-energy phosphate production or utilization in the course of cardiac work might be expected to incorporate labeled nucleotides at rates reflecting the work load imposed. Evidence has been recently obtained for the in vivo incorporation of acidsoluble nucleoside 5'-mouophosphate units (presumably as residues of the corresponding Circulation Research, Volume VIII, July I960 Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 LABELED PHOSPHATE DISTRIBUTION 711 di- or tri-phosphates) into mammalian liver RNA (to be published). Isotope present in the carbon-bound P groups of the acid-soluble nucleotides, therefore, represents the entering label into the RNA molecule. Maximum incorporation of isotope into RNA cannot consequently exceed the level of incorporation in the carbon-bound P groups of the acid-soluble nucleotide pools. The results of an experiment of phosphateP 32 incorporation into RNA nucleotides in working and nonworking myocardium have been summarized in table 6. The nucleotide composition of RNA from the working left and nonworking right ventricles has also been presented. The results indicate little significant difference in composition or isotope incorporation in the RNA of working as compared with nonworking myocardium. These results have been presented to document an apparent lack of participation of RNA in the work function of cardiac muscle. Table 6 Effect of Work on Labeled P Incorporation into Cardiac BNA* Summary Investigation of phosphate metabolism with the aid of labeled phosphorus has been carried out, using isolated heart preparations in which only the left ventricles perform external work. The corresponding right ventricles in such preparations perform no external work with the unique experimental advantage of a single heart, providing simultaneously both working and "resting" (nonworking) metabolic states. Comparative incorporation of labeled phosphorus into nucleotide phosphate groups, nonnucleotide soluble phosphorylated components, phospholipids and ribose nucleic acid was examined as a function of cardiac work. Incorporation of the label into the rapidly exchanged high-energy phosphate groups was found to be restricted by a prior rate—limiting entry of the externally perfused isotope into the cells, thereby precluding a measure of turnover of these groups by this technic. Differences could not be demonstrated in isotope incorporation in either the phospholipids or RNA of working as compared to nonworking myocardium. It was concluded from Circulation Research, Volume VIII, July I960 w a. S.A. (c.p.m./ £ a Working (LV) Cone. rel. to AMP Cone. rel. to AMP Nucleotidet Nonworking (RV) AMP (2', 3') GMP (2', 3') CMP (2', 3') — 560 — 360 1.06 480 1.12 380 1.28 470 1.43 380 UPM (2', 3') 0.70 790 0.77 700 — 300,000 — 260,000 (P.) "Cardiac preparation no. 5 (see table 1) was employed for the RNA analyses. Isotope perfusion was for 40 minutes, followed by a 15-minute wash. tFor details concerning the isolation and specific activity measure of RNA nucleotides, sec "Procedures. ' ' these results that RNA is clearly not involved in energy reactions associated with cardiac work function. Phospholipid participation, on the other hand, could be clearly excluded only insofar as the phosphate moiety of these compounds is concerned. Information relevant to a mechanism of phosphate entry into cardiac cells was obtained in which a phosphorylation of hexose appeared to be involved. The composition of cardiac tissue with respect to nucleotide and non-nucleotide soluble components was examined in working and nonworking myocardium. Differences in composition were not: found with respect to these constituents. A major component appearing in extracts of cardiac tissue was found and subsequently identified to be a-glycerophosphate. On the basis of isotope incorporation data, it was concluded that its metabolic source was of carbohydrate rather than phospholipid origin. • Summario in Interlingua Con le adjuta de marcation a phosphoro radioactive, le metabolismo de phosphato esseva investigate in cordes isolate preparate de maniora que solmente le ventriculos sinistre es externemente active. In till preparatos, le correspondente ventriculo dextcrc es TSUBOI, BUCKLEY, ZEIG 712 Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 externemente inactive. Isto resulta in le exquisite avantage experimental quo le niesnie eorde provide siniultaiieeniente active e inactive (i.e. "reposante") statos metabolic. Le incorporation del phosphoro radioactive in gruppos de phospliato nucleotidic, in solubile componentes phospliorj'lnte non-nuclcotidie, in phospholipidos, e in acido ribonucleic esseva studiate comparntivemente como function del labor cardiac. Le incorporation del marca in le rapidemente excambiate gruppos phospliatic a alte energia se revelava como rcstringite per le effecto inliibitori del previe entrata del extornemente perfusionate isotopo a in le cellula. Isto rendeva iinpossibile lo determination del rhythmo metabolic do iste gruppos per medio del presentc technica. Nullc differentias potova esser demonstrate in le incorporation del isotopo in phospliolipidos o in acido ribonucleic in le myocardio active in comparation con le myocardio in roposo. Super le base de iste resultatos il esseva concludite quo acido ribonucleic es nottemente oxempte ab oiniic participation in le reactiones do energia quo os associate con le function de travalio del parte del corde. Del altero latore, lc participation do phospliolipidos poteva esscr excludite nettemente solmentc con rospecto al componente phospliatic dc isto coinpositos. Infornintioncs do interessc eon rospecto al inechanismo del entrata de phosphato in le cellulas cardiac esseva obtenite, suggerento que un phosphorylation de liexosa occurre in le processo. Lo composition de tissu cardiac con respecto a solubile componentes nucleotidic o non-nucleotidic esseva examinate pro le myocardio active e reposante. Nulle difforentias do composition esseva constatate con respecto al constituontes nientionate. Essevn trovato un componente major in extractos do tissu cardiac, le qual—subsequentementc—essova identificate como glycerophosphato alpha. Super lo base del datos relative al incorporation del isotopo, le conclusion esseva formulate que le origine metabolic de i 1 le componente esseva in liydratos de carbon plus tosto quo in phospliolipidos. ties of a polynucleotide from adenosine polyphasphate. Nature 177: 790, 1956. (i. lateral ventricular failure in the isolated dog heart. Am. J. Physiol. 197: 247, 1959. 7. TSUBOI, K. K., AND PRICE, T. D.: Isolation, de- tection and measure of mierogram quantities of labeled tissue nucleotides. Arch. Biochem. 81: 223, 1959. 8. —•: Labeled phosphorus distribution in nucleoside polyphosphatos: Adeniue nuelootides of rat tissues. Arch. Biochem. 83: 445, 1959. 9. —, AND STOWELL, R. E.: Mouse liver nucleic acids. I. Isolation and chemical characterization. Biochim. et biophys. acta 6: 192, 3950. 10. HERHERT, EDWARD: Incorporation of adenine nucleotides into ribonucleic acid of cell-free systems from liver. J. Biol. Chem. 231: 975, 1958. 11. MAGASANIK, B., YISCHER, E., DONINGER, R., ELSON, D., AND CHARGAFF, E.: Separation and estimation of ribonuelcotides in minute quantities. J. Biol. Chem. 186: 37, 1950. .12. MONTREUIL, J., AND BOULANGER, P.: Analyse Biochomiquo. Chroma tographie Quantitative sur Papier des Ribonucleotidcs. Compt. rend. 231: 247, 1950. 13. HANES, C. S., AND ISHERWOOD, !F. A.: Separation of the phosphoric esters on the filter paper chromatogram. Nature 164: 1107, 1949. J4. BANDURSKI, R. S., AND AXELROD, B.: Chroma- tographio identification of some biologically important phosphate esters. J. Biol. Chem. 193: 405, 1952. :15. PRICE, T. D., AND HUDSON, P. B.: Specific activity determination with beta and TJV-photon counter. Nucleonics 13: 54, 1955. 36. FISKE, C. H., AND SUBBAROW, Y.: Colorimetric determination of phosphorus. 66: 375, 1925. J. Biol. Chem. .17. FEIGEN, G. A., MATSUOKA, D. T., THIENES, C. H., SAUNDERS, P. R., AND SUTHERLAND, G. B.: Mechanical response of the isolated rat ventricle strip. Stanford Med. Bull. 10: 27, 1952. References J. Bl'CKLEY, N . M., SlDKY, M., AND OODEN, B . : BUCKLEY, N. M., AND ZEIG, N. J.: Acute uni- 18. KALCKAR, H. M., DEHUNGER, J., AND MEHLER, Factors altering the filling of the isolated left, ventricle of the dog heart. Circulation Resoarch 4: 148, 1956. 2. BING, 1?. J.: Metabolism of the heart. Harvey Lecture 50: 27, 1954-1955. 3. CAVERT, H. M.: Some current, views on the biochemistry and physiology of myocardial contraction. Bull. New York Acad. Med. 34: 445, 1958. 19. 4. GRUNBERG-MANAGO, M., AND OCHOA, S.: Enzy- 20. MARSH, J. B., CASTEN, G. G., AND ELLIOT, H. F . : matic synthesis and breakdown of polynucleotides; polynucleotide phosphorylase. J. Am. Chem. Soc. 77: 3165, 1955. 5. BEERS, R. F . : Enzymatic synthesis and proper- Uptake of P32 by cardiac muscle in vivo. Am. J. Physiol. 173: 297, 1953. A.: Rejuvenation of phosphate in adenine mieleotides. I I . Rate of rejuvenation of labile phosphate compounds in muscle and liver. J. Biol. Chem. 154: 275, 1944. SCHAEFEER, J.: Einbau von P"~ in die saurelos- lichen Nucleotide dos Herzmuskels der Ratte bei Stbrungon des Electrolyt und Wasserhaushaltes. Arch, exper. Path. u. Pharmakol. 236: 168, 1959. 21. PANGBORN, M. C.: Composition of cardiolipin. J. Biol. Chem. 168: 351, 1947. Circulation Research, Volume VIII, July 1960 Labeled Phosphate Distribution in Working and Nonworking Myocardium KENNETH K. TSUBOI, NANCY M. BUCKLEY and NORMAN J. ZEIG Downloaded from http://circres.ahajournals.org/ by guest on June 15, 2017 Circ Res. 1960;8:703-712 doi: 10.1161/01.RES.8.4.703 Circulation Research is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 1960 American Heart Association, Inc. All rights reserved. Print ISSN: 0009-7330. Online ISSN: 1524-4571 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circres.ahajournals.org/content/8/4/703 Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Circulation Research can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Circulation Research is online at: http://circres.ahajournals.org//subscriptions/